Earnings History Data for INmune Bio Inc. (INMB) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
INmune Bio Inc.
INmune Bio Inc. is a clinical-stage biotechnology company. It engages in developing therapies targeting the innate immune system in cancer. The company's product platform consists of INKmune and INB03. INKmune is a natural killer cell therapeutic which primes the patient's NK cells to attack developing disease. INB03 inhibits myeloid derived suppressor cells which often cause resistance to immunotherapy, such as anti-PD1 checkpoint inhibitors. INmune Bio Inc. is based in La Jolla, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31-10-2024 | AH | INMB | INmune Bio Inc. | 124.63 | -0.60 | -0.49 | -0.48 | INmune Bio GAAP EPS of -$0.60 misses by $0.10 [10/31/2024 4:12 PM] |
6.02 | 0.17 (2.91%) |
6.15 | 0.30 (5.13%) |
4.78 - 14.74 | 204,133 | 300,000 | 2,253 | ||
| 01-08-2024 | AH | INMB | INmune Bio Inc. | 163.40 | -0.50 | 0.00 | -0.36 | INmune Bio GAAP EPS of -$0.50 beats by $0.13 [8/1/2024 4:22 PM] |
8.23 | 0.32 (4.05%) |
7.89 | -0.02 (-0.25%) |
6.50 - 14.74 | 173,040 | 150,000 | 26,002 | ||
| 09-05-2024 | AH | INMB | INmune Bio Inc. | 201.54 | -0.61 | 0.00 | -0.36 | INmune Bio reports Q1 GAAP EPS of -$0.61 [5/9/2024 4:40 PM] |
10.04 | -0.73 (-6.82%) |
10.49 | -0.28 (-2.60%) |
6.50 - 14.74 | 141,420 | 170,000 | 1,013 | ||
| 01-11-2023 | AH | INMB | INmune Bio Inc. | 121.83 | -0.48 | 0.00 | -0.43 | INmune Bio GAAP EPS of -$0.48 misses by $0.09 [11/1/2023 4:57 PM] |
6.80 | -0.27 (-3.82%) |
6.50 | -0.57 (-8.06%) |
5.87 - 11.26 | 30,342 | 30,000 | 882 | ||
| 07-08-2023 | AH | INMB | INmune Bio Inc. | 154.69 | -0.36 | 0.00 | -0.38 | INmune Bio GAAP EPS of -$0.36 beats by $0.04 [8/7/2023 4:41 PM] |
7.88 | -0.88 (-10.05%) |
8.40 | -0.36 (-4.11%) |
5.75 - 11.26 | 89,950 | 30,000 | 2,201 | ||
| 03-05-2023 | AH | 4:00 PM ET (May 3) |
INMB | INmune Bio Inc. | 126.88 | -0.36 | 0.00 | -0.39 | INmune Bio GAAP EPS of -$0.36 [5/3/2023 4:48 PM] |
7.56 | 0.31 (4.28%) |
0.0 | 0.0 (0.00%) |
4.63 - 10.75 | 45,993 | 30,000 | 0 | |
| 02-03-2023 | AH | 4:00 PM ET (Mar 2) |
INMB | INmune Bio Inc. | 162.23 | -0.32 | 0.00 | -0.55 | INmune Bio GAAP EPS of -$1.52 beats by $0.14, revenue of $0.37M beats by $0.17M [3/2/2023 4:28 PM] |
8.75 | -0.69 (-7.31%) |
0.0 | 0.0 (0.00%) |
4.63 - 10.75 | 123,714 | 30,000 | 0 | |
| 02-11-2022 | AH | 4:10 PM ET (Nov 2) |
INMB | INmune Bio Inc. | 137.65 | -0.43 | -0.59 | -0.55 | INmune Bio GAAP EPS of -$0.43 [11/2/2022 4:57 PM] |
7.51 | 0.29 (4.02%) |
7.10 | -0.12 (-1.66%) |
4.63 - 20.00 | 29,791 | 30,000 | 304 | |
| 03-08-2022 | AH | 4:00 PM ET (Aug 3) |
INMB | INmune Bio Inc. | 167.44 | -0.38 | -0.50 | -0.44 | INmune Bio GAAP EPS of -$0.38 [8/3/2022 4:17 PM] |
10.31 | 0.26 (2.59%) |
3.92 | -0.40 (-9.26%) |
4.63 - 30.37 | 50,173 | 60,000 | 51,552 | |
| 05-05-2022 | AH | 4:00 PM ET (May 5) |
INMB | INmune Bio Inc. | 141.77 | -0.39 | -0.60 | -0.32 | INmune Bio GAAP EPS of -$0.39, revenue of $0.2M [5/5/2022 4:05 PM] |
7.54 | 0.31 (4.29%) |
7.47 | 0.24 (3.32%) |
6.18 - 30.37 | 90,088 | 140,000 | 1,184 | |
| 03-03-2022 | AH | 4:15 PM ET (Mar 3) |
INMB | INmune Bio Inc. | 157.02 | -0.55 | -0.56 | -0.24 | INmune Bio GAAP EPS of -$1.88 misses by $1.30, revenue of $0.18M [3/3/2022 4:03 PM] |
7.83 | 0.02 (0.26%) |
8.10 | 0.29 (3.71%) |
7.64 - 30.37 | 150,744 | 160,000 | 368 | |
| 03-11-2021 | AH | 4:20 PM ET (Nov 3) |
INMB | INmune Bio Inc. | 345.42 | -0.55 | -0.43 | -0.36 | INmune Bio EPS misses by $0.19 [11/3/2021 4:36 PM] |
17.63 | -1.90 (-9.73%) |
18.91 | -0.62 (-3.17%) |
7.46 - 30.37 | 369,508 | 190,000 | 2,858 | |
| 04-08-2021 | AH | 4:15 PM ET (Aug 4) |
INMB | INmune Bio Inc. | 258.04 | -0.44 | -0.33 | -0.20 | INmune Bio EPS misses by $0.10 [8/4/2021 4:40 PM] |
14.98 | 0.85 (5.98%) |
13.50 | -0.63 (-4.46%) |
7.28 - 29.99 | 582,599 | 660,000 | 636 | |
| 05-05-2021 | AH | 4:15 PM ET (May 5) |
INMB | INmune Bio Inc. | 177.25 | -0.32 | -0.28 | -0.19 | INmune Bio EPS misses by $0.05 [5/5/2021 4:35 PM] |
10.46 | -0.61 (-5.51%) |
10.71 | -0.36 (-3.25%) |
4.50 - 29.99 | 273,413 | 100,000 | 400 | |
| 04-03-2021 | AH | 4:00 PM ET (Mar 4) |
INMB | INmune Bio Inc. | 246.64 | -0.24 | -0.33 | -0.22 | INmune Bio reports Q4 results [3/4/2021 4:40 PM] |
14.42 | -0.96 (-6.21%) |
15.50 | 0.13 (0.85%) |
2.20 - 29.99 | 644,330 | 244,705 | 2,476 | |
| 05-11-2020 | AH | 4:00 PM ET (Nov 5) |
INMB | INmune Bio Inc. | 108.79 | -0.36 | -0.17 | -0.28 | INmune Bio EPS misses by $0.19 [11/5/2020 5:43 PM] |
7.69 | -0.76 (-8.99%) |
7.82 | -0.63 (-7.46%) |
2.20 - 24.42 | 171,720 | 103,863 | 337 | |
|
|
||||||||||||||||||
| 05-08-2020 | AH | After the close (Aug 5) |
INMB | INmune Bio Inc. | 156.00 | -0.20 | -0.18 | -0.04 | INmune Bio EPS beats by $0.03 [8/5/2020 4:34 PM] |
11.69 | -0.18 (-1.53%) |
12.00 | 0.13 (1.10%) |
2.20 - 24.42 | 147,686 | 424,480 | 4,116 | |
|
|
||||||||||||||||||
| 14-05-2020 | PM | INMB | INmune Bio Inc. | 57.07 | -0.19 | -0.21 | 0.00 | INmune Bio EPS beats by $0.02 [5/14/2020 3:11 PM] |
5.51 | 0.15 (2.80%) |
5.50 | 0.14 (2.61%) |
2.20 - 11.50 | 33,517 | 49,391 | 230 | ||
|
|
||||||||||||||||||